Jeffrey W. Ubben, Director at Enviva Inc. (EVA), bought 143,844 shares at $51.06 ($7.3M) on 2022-10-14, disclosed to the SEC on 2022-10-14.
Open-market purchase of $7.3M EVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.97 | 1,446 | $72K | 1.0% |
| 2 | $49.97 | 1,446 | $72K | 1.0% |
| 3 | $48.51 | 3,071 | $149K | 2.0% |
| 4 | $48.51 | 3,071 | $149K | 2.0% |
| 5 | $50.13 | 29,465 | $1.5M | 20.3% |
| 6 | $50.13 | 29,465 |
| $1.5M |
| 20.3% |
| 7 | $51.06 | 33,416 | $1.7M | 23.5% |
| 8 | $51.06 | 33,416 | $1.7M | 23.5% |
| 9 | $51.50 | 9,048 | $466K | 6.4% |
| Total | $50.58 avg | 143,844 | $7.3M | 100% |
| Filing → |
| XOM | BUY | 2023-11-08 | $21.2M | — | Filing → |
| XOM | BUY | 2023-08-03 | $33.8M | — | Filing → |
| XOM | BUY | 2023-08-02 | $63.9M | — | Filing → |